The effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC-HF).
Citation: European Journal of Heart Failure. 23(6):1052-1056, 2021 06.PMID: 33826209Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): LetterSubject headings: *Heart Failure | *Heart Failure, Systolic | Cardiac Myosins | Heart Failure, Systolic/dt [Drug Therapy] | Heart Failure/dt [Drug Therapy] | Humans | Stroke Volume | Urea/aa [Analogs & Derivatives]Year: 2021ISSN:- 1388-9842
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 33826209 | Available | 33826209 |
English